March 2024
1. DING X, Qiu Y, Wu G, Li S, et al
   l-thyroxine attenuates extracellular Hsp90alpha-induced vascular endothelial calcification in diabetes mellitus, as revealed by parallel metabolic profiles.
   Atherosclerosis. 2024;392:117527.
   

   >> Share

   
   
2. VARGAS-VAZQUEZ A, Fermin-Martinez CA, Antonio-Villa NE, Fernandez-Chirino L, et al
   Insulin resistance potentiates the effect of remnant cholesterol on cardiovascular mortality in individuals without diabetes.
   Atherosclerosis. 2024 Mar 13:117508. doi: 10.1016/j.atherosclerosis.2024.117508.
   

   >> Share

   
   February 2024
3. KIM H, Choi CU, Rhew K, Park J, et al
   Comparative effects of glucose-lowering agents on endothelial function and arterial stiffness in patients with type 2 diabetes: A network meta-analysis.
   Atherosclerosis. 2024;391:117490.
   

   >> Share

   
   
4. NOVO G, Arcari L, Stiermaier T, Alaimo C, et al
   Statin therapy and outcome in Takotsubo syndrome patients: Results from the multicenter international GEIST registry.
   Atherosclerosis. 2024;389:117421.
   

   >> Share

   
   November 2023
5. JOSHI P, Mohr F, Rumig C, Kliemank E, et al
   Impact of the -1T>C single-nucleotide polymorphism of the CD40 gene on the development of endothelial dysfunction in a pro-diabetic microenvironment.
   Atherosclerosis. 2023 Nov 14:117386. doi: 10.1016/j.atherosclerosis.2023.117386.
   

   >> Share

   
   
6. GAGNON E, Paulin A, Mitchell PL, Arsenault BJ, et al
   Disentangling the impact of gluteofemoral versus visceral fat accumulation on cardiometabolic health using sex-stratified Mendelian randomization.
   Atherosclerosis. 2023;386:117371.
   

   >> Share

   
   
7. ZUBIRAN R, Vargas-Vazquez A, Olvera FDR, Cruz-Bautista I, et al
   Performance of the enhanced Sampson-NIH equation for VLDL-C and LDL-C in a population with familial combined hyperlipidemia.
   Atherosclerosis. 2023;386:117364.
   

   >> Share

   
   
8. ANTZA C, Gallo A, Boutari C, Ershova A, et al
   Prevention of cardiovascular disease in young adults: Focus on gender differences. A collaborative review from the EAS Young Fellows.
   Atherosclerosis. 2023;384:117272.
   

   >> Share

   
   
9. LARSSON J, Auscher S, Shamoun A, Pararajasingam G, et al
   Insulin resistance is associated with high-risk coronary artery plaque composition in asymptomatic men between 65 and 75 years and no diabetes: A DANCAVAS cross-sectional sub-study.
   Atherosclerosis. 2023;385:117328.
   

   >> Share

   
   October 2023
10. ZHANG YR, Liu SM, Chen Y, Zhang LS, et al
    Intermedin alleviates diabetic vascular calcification by inhibiting GLUT1 through activation of the cAMP/PKA signaling pathway.
    Atherosclerosis. 2023;385:117342.
    

    >> Share

    
    
11. MEER R, Romero Prats ML, Vervloet MG, van der Schouw YT, et al
    The effect of six-month oral vitamin K supplementation on calcification propensity time in individuals with type 2 diabetes mellitus: A post hoc analysis of a randomized, double-blind, placebo-controlled trial.
    Atherosclerosis. 2023 Oct 6:117307. doi: 10.1016/j.atherosclerosis.2023.117307.
    

    >> Share

    
    
12. CHAIT A, Eckel RH, Vrablik M, Zambon A, et al
    Lipid-lowering in diabetes: An update.
    Atherosclerosis. 2023 Oct 6:117313. doi: 10.1016/j.atherosclerosis.2023.117313.
    

    >> Share

    
    
13. YANG F, Wang M, Du J, Fu Y, et al
    Predicting life span of type 2 diabetes patients through alkaline phosphatase and vitamin D: Results from NHANES 1999-2018.
    Atherosclerosis. 2023 Oct 5:117318. doi: 10.1016/j.atherosclerosis.2023.117318.
    

    >> Share

    
    September 2023
14. JONAS M, Genereux P, Maehara A, Ben-Yehuda O, et al
    Control of diabetes mellitus and the risk of neointimal hyperplasia after percutaneous coronary intervention: Post-hoc analysis from the BLADE-PCI trial.
    Atherosclerosis. 2023 Sep 3:117264. doi: 10.1016/j.atherosclerosis.2023.117264.
    

    >> Share

    
    August 2023
15. ZHAO JV, Fan B, Burgess S
    Using genetics to examine the overall and sex-specific associations of branch-chain amino acids and the valine metabolite, 3-hydroxyisobutyrate, with ischemic heart disease and diabetes: A two-sample Mendelian randomization study.
    Atherosclerosis. 2023;381:117246.
    

    >> Share

    
    
16. MARTAGON AJ, Zubiran R, Gonzalez-Arellanes R, Praget-Bracamontes S, et al
    HDL abnormalities in type 2 diabetes: Clinical implications.
    Atherosclerosis. 2023 Aug 3:117213. doi: 10.1016/j.atherosclerosis.2023.117213.
    

    >> Share

    
    July 2023
17. REIJRINK M, Sluiter JKE, Te Velde-Keyzer CA, de Borst MH, et al
    Severely increased albuminuria in patients with type 2 diabetes mellitus is associated with increased subclinical atherosclerosis in femoral arteries with Na [(18)F]F activity as a proxy - The DETERMINE study.
    Atherosclerosis. 2023 Jul 29:117199. doi: 10.1016/j.atherosclerosis.2023.117199.
    

    >> Share

    
    
18. YANG XH, Tu QM, Li L, Guo YP, et al
    Triglyceride-lowering therapy for the prevention of cardiovascular events, stroke, and mortality in patients with diabetes: A meta-analysis of randomized controlled trials.
    Atherosclerosis. 2023 Jul 13:117187. doi: 10.1016/j.atherosclerosis.2023.117187.
    

    >> Share

    
    
19. BARFOROSHI S, Manubolu VS, Wang R, McClelland RL, et al
    Incremental value of ABI and CAC beyond traditional risk markers in long-term prediction of cardiovascular disease incidence in participants with diabetes and impaired fasting glucose: Multi-Ethnic Study of Atherosclerosis.
    Atherosclerosis. 2023 Jul 6:117186. doi: 10.1016/j.atherosclerosis.2023.117186.
    

    >> Share

    
    
20. ROCA F, Zmuda L, Noel G, Duflot T, et al
    Changes in carotid arterial wall viscosity and carotid arterial stiffness in type 2 diabetes patients.
    Atherosclerosis. 2023 Jul 6:117188. doi: 10.1016/j.atherosclerosis.2023.117188.
    

    >> Share

    
    
21. HAMAYA R, Mora S
    Young, hot and sweet: The complex relationship of inflammation, type 1 diabetes, and vascular health.
    Atherosclerosis. 2023 Jul 5:117184. doi: 10.1016/j.atherosclerosis.2023.117184.
    

    >> Share

    
    
22. JIN S, Eussen SJPM, Schalkwijk CG, Stehouwer CDA, et al
    Plasma factor D is cross-sectionally associated with low-grade inflammation, endothelial dysfunction and cardiovascular disease: The Maastricht study.
    Atherosclerosis. 2023;377:60-67.
    

    >> Share

    
    June 2023
23. NIELSEN S, Nyvad J, Christensen KL, Poulsen PL, et al
    Obstructive sleep apnea, coronary calcification and arterial stiffness in patients with diabetic kidney disease.
    Atherosclerosis. 2023 Jun 29:117170. doi: 10.1016/j.atherosclerosis.2023.
    

    >> Share

    
    
24. SUN Z, Zhang L, Yin K, Zang G, et al
    SIRT3-and FAK-mediated acetylation-phosphorylation crosstalk of NFATc1 regulates N(epsilon)-carboxymethyl-lysine-induced vascular calcification in diabetes mellitus.
    Atherosclerosis. 2023;377:43-59.
    

    >> Share

    
    
25. VERGES B
    Cardiovascular disease in type 1 diabetes, an underestimated danger: Epidemiological and pathophysiological data.
    Atherosclerosis. 2023 Jun 20:S0021-9150(23)00244.
    

    >> Share

    
    
26. SIMEUNOVIC A, Brunborg C, Heier M, Seljeflot I, et al
    Sustained low-grade inflammation in young participants with childhood onset type 1 diabetes: The Norwegian atherosclerosis and childhood diabetes (ACD) study.
    Atherosclerosis. 2023 Jun 4:S0021-9150(23)00225.
    

    >> Share

    
    May 2023
27. KUEHNEMUND L, Lange SA, Feld J, Padberg JS, et al
    Sex disparities in guideline-recommended therapies and outcomes after ST-elevation myocardial infarction in a contemporary nationwide cohort of patients over an eight-year period.
    Atherosclerosis. 2023;375:30-37.
    

    >> Share

    
    
28. VAN EENIGE R, Ying Z, Tramper N, Wiebing V, et al
    Combined glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonism attenuates atherosclerosis severity in APOE*3-Leiden.CETP mice.
    Atherosclerosis. 2023;372:19-31.
    

    >> Share

    
    February 2023
29. MA Y, Li D, Xie J, Hu Y, et al
    Exposure to various ambient air pollutants and 9 cardiovascular conditions among individuals with diabetes: A prospective analysis of the UK Biobank.
    Atherosclerosis. 2023;369:1-8.
    

    >> Share

    
    
30. LI N, Zhang X, Zhang M, Wu L, et al
    Associations of genetically determined lipid traits and lipid-modifying agents with the risk of diabetic retinopathy: A Mendelian randomization study.
    Atherosclerosis. 2023;369:9-16.
    

    >> Share

    
    January 2023
31. TESORIO T, Mone P, de Donato A, Trimarco V, et al
    Linking lifestyle factors to cardiovascular risk through metabolomics: Insights from a large population of diabetic patients followed-up for 11 years.
    Atherosclerosis. 2023 Jan 21:S0021-9150(23)00024.
    

    >> Share

    
    
32. WASIAK S, Tsujikawa LM, Daze E, Gilham D, et al
    Epigenetic BET reader inhibitor apabetalone (RVX-208) counters proinflammatory aortic gene expression in a diet induced obesity mouse model and in human endothelial cells.
    Atherosclerosis. 2023;364:10-19.
    

    >> Share

    
    December 2022
33. LU Q, Chen J, Li R, Wang Y, et al
    Healthy lifestyle, plasma metabolites, and risk of cardiovascular disease among individuals with diabetes.
    Atherosclerosis. 2022 Dec 26:S0021-9150(22)01569.
    

    >> Share

    
    November 2022
34. ALEXOPOULOS N, Raggi P
    The importance of targeting epicardial adipose tissue to improve cardiovascular outcomes in diabetes mellitus.
    Atherosclerosis. 2022 Nov 10:S0021-9150(22)01504.
    

    >> Share

    
    October 2022
35. TESCHE C, Bauer MJ, Straube F, Rogowski S, et al
    Association of epicardial adipose tissue with coronary CT angiography plaque parameters on cardiovascular outcome in patients with and without diabetes mellitus.
    Atherosclerosis. 2022 Oct 17. pii: S0021-9150(22)01477.
    

    >> Share

    
    
36. WU S, Yang YM, Zhu J, Xu W, et al
    Impact of glycemic gap on 30-day adverse outcomes in patients with acute ST-segment elevation myocardial infarction.
    Atherosclerosis. 2022;360:34-41.
    

    >> Share

    
    August 2022
37. VARLEY BJ, Nasir RF, Craig ME, Gow ML, et al
    Early life determinants of arterial stiffness in neonates, infants, children and adolescents: A systematic review and meta-analysis.
    Atherosclerosis. 2022;355:1-7.
    

    >> Share

    
    July 2022
38. SALEM AM, Bain SC, Obaid DR
    Glucagon-like peptide-1 receptor agonists as anti-inflammatory agents: A potential mode of cardiovascular benefits.
    Atherosclerosis. 2022;352:83-84.
    

    >> Share

    
    June 2022
39. WANG J, Lee SY, Chao CT, Huang JW, et al
    The frailty risk trajectory associated with kidney and cardiovascular morbidities among patients with incident diabetes: A population-based study.
    Atherosclerosis. 2022 Jun 14. pii: S0021-9150(22)01297.
    

    >> Share

    
    
40. SORENSEN IM, Bisgaard LS, Bjergfelt SS, Ballegaard EL, et al
    The metabolic signature of cardiovascular disease and arterial calcification in patients with chronic kidney disease.
    Atherosclerosis. 2022;350:109-118.
    

    >> Share

    
    May 2022
41. LAMINA C, Ward NC
    Lipoprotein (a) and diabetes mellitus.
    Atherosclerosis. 2022;349:63-71.
    

    >> Share

    
    April 2022
42. NAKAMURA H, Kataoka Y, Nicholls SJ, Puri R, et al
    Elevated Lipoprotein(a) as a potential residual risk factor associated with lipid-rich coronary atheroma in patients with type 2 diabetes and coronary artery disease on statin treatment: Insights from the REASSURE-NIRS registry.
    Atherosclerosis. 2022 Apr 10. pii: S0021-9150(22)00166.
    

    >> Share

    
    March 2022
43. CHO IY, Chang Y, Sung E, Kim Y, et al
    Fasting ketonuria is inversely associated with coronary artery calcification in non-diabetic individuals.
    Atherosclerosis. 2022;348:1-7.
    

    >> Share

    
    February 2022
44. LEONETTI S, Trico D, Nesti L, Baldi S, et al
    Soluble CD40 receptor is a biomarker of the burden of carotid artery atherosclerosis in subjects at high cardiovascular risk.
    Atherosclerosis. 2022;343:1-9.
    

    >> Share

    
    January 2022
45. YOSHIDA Y, Chen Z, Baudier RL, Krousel-Wood M, et al
    Menopausal hormone therapy and risk of cardiovascular events in women with prediabetes or type 2 diabetes: A pooled analysis of 2917 postmenopausal women.
    Atherosclerosis. 2022;344:13-19.
    

    >> Share

    
    
46. IQBAL Z, Bashir B, Adam S, Ho JH, et al
    Glycated apolipoprotein B decreases after bariatric surgery in people with and without diabetes: A potential contribution to reduction in cardiovascular risk.
    Atherosclerosis. 2022;346:10-17.
    

    >> Share

    
    December 2021
47. SUNDQUIST K, Sundquist J, Palmer K, Memon AA, et al
    Role of mitochondrial DNA copy number in incident cardiovascular diseases and the association between cardiovascular disease and type 2 diabetes: A follow-up study on middle-aged women.
    Atherosclerosis. 2021 Dec 1. pii: S0021-9150(21)01448.
    

    >> Share

    
    November 2021
48. SAMSKY MD, Mentz RJ, Stebbins A, Lokhnygina Y, et al
    Polyvascular disease and increased risk of cardiovascular events in patients with type 2 diabetes: Insights from the EXSCEL trial.
    Atherosclerosis. 2021;338:1-6.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share